2016 NCI SBIR Workshop on Facilitating the Development of Molecularly Targeted Radiotherapy
|
Training Initiative
|
FDA
|
NCI
|
2017
|
|
A Pilot Study of Urinary Carcinogen Biomarkers in the Golestan Cohort Study
|
Research Initiative
|
CDC, FDA
|
NCI
|
2015
|
|
Abuse Liability Evaluation for Research, Treatment, and Training (ALERTT)
|
Research Initiative
|
FDA
|
NIDA
|
2011
|
|
Accelerating Medicines Partnership
|
Other
|
FDA
|
NIA, NIAMS, NIDDK, NINDS, OD/ OSP
|
2014
|
|
AccessGUDID
|
Resource Development
|
FDA
|
NLM
|
2015
|
|
Adjuvant Working Group
|
Committee, Advisory Group, or Work Group
|
BARDA, FDA
|
NCI, NIAID
|
2013
|
|
Advanced Anticonvulsant System Interagency Product Team
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
NINDS
|
2011
|
|
Adverse Event Reporting and Medical Countermeasures
|
Resource Development
|
FDA
|
NLM
|
2013
|
|
Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
CC, NHLBI
|
2003
|
|
Advisory Committee on Heritable Disorders in Newborn and Children
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA
|
NICHD
|
2014
|
|
AIDSinfo/InfoSIDA
|
Public Education Campaign
|
CDC, FDA, HRSA
|
NIAID, NLM, OD/ DPCPSI/ OAR
|
2002
|
|
Alcohol Clinical Trial Initiative (ACTIVE)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAAA, NIDA
|
2007
|
|
Alzheimer's Disease Neuroimaging Initiative (ADNI)
|
Research Initiative
|
FDA
|
NIA, NIBIB
|
2004
|
|
American Academy of Pediatrics (AAP) Committee on Drugs
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD
|
Unknown
|
|
American Conference for the Treatment of HIV (ACTHIV)
|
Meeting/ Workshop
|
CDC, FDA, HRSA
|
NICHD, NIMH, OD/ DPCPSI/ OAR
|
2005
|
|
Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks
|
Research Initiative
|
FDA
|
NCATS, NCI, NIAAA, NIDA, NINDS
|
2011
|
|
Antimicrobial Drugs Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2007
|
|
Antiretroviral Pregnancy Registry
|
Resource Development
|
CDC, FDA, HRSA
|
NICHD
|
1989
|
|
Arthritis Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2017
|
|
Assay Guidance Workshop For High Throughput Screening And Lead Discovery
|
Meeting/ Workshop
|
FDA
|
NCATS, NCI, NIAAA, NIDDK
|
2015
|
|
ASTM International F-2529-13--Standard Guide for In-Vivo Evaluation of Osteoinductive Potential for Materials Containing Demineralized Bone (DBM)
|
Research Initiative
|
FDA
|
NIDCR
|
2015
|
|
Autoimmune Diseases Coordinating Committee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
CSR, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR
|
1998
|
|
Bacteriophage Therapy: Scientific and Regulatory Issues Public Workshop
|
Meeting/ Workshop
|
FDA
|
NIAID
|
2016
|
|
Best Pharmaceuticals for Children Act (BPCA) Data Monitoring Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD
|
2009
|
|
Best Pharmaceuticals for Children Act (BPCA) Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD
|
Unknown
|
|
|